Corpus overview


Overview

MeSH Disease

Human Phenotype

Cataract (1)


Transmission

There are no transmission terms in the subcorpus


Seroprevalence

There are no seroprevalence terms in the subcorpus

    displaying 1 - 1 records in total 1
    records per page




    Cataract HP Cataract MESHD Services in the COVID-19 era: Risk, Consent and Prioritisation

    Authors: Dr Kelvin Cheng; Dr Martin Anderson; Dr Stavros Velissaris; Dr Robert Moreton; Dr Ahmed Al-Mansour; Professor Roshini Sanders; Dr Shona Sutherland; Dr Peter Wilson; Dr Andrew Blaikie

    doi:10.21203/rs.3.rs-72755/v1 Date: 2020-09-05 Source: ResearchSquare

    Background:The COVID-19 pandemic halted non-emergency surgery across Scotland. Measures to mitigating the risks of transmitting COVID-19 are creating significant challenges to recommencement of all surgical services safely. We describe the development of a risk stratification tool to prioritise patients for cataract HP cataract MESHD surgery and report the demographics and comorbidities of patients on the NHS Fife waiting list. Methods:A prospective case review of electronic records was performed. A risk stratification tool was developed based on review of available literature on risk factors for poor outcome from COVID-19 infection MESHD. Scores derived from the tool were used to generate 6 risk profile groups to call in time order for surgery.Results:There were 744 patients awaiting cataract HP cataract MESHD surgery of which 66 (8.9%) patients were ‘shielding’. One hundred and thirty-two (19.5%) patients had no systemic comorbidities, 218 (32.1%) patients had 1 relevant systemic comorbidity and 316 (46.5%) patients had 2 or more comorbidities. Five hundred and ninety patients (88.7%) did not have any ocular comorbidities.Conclusions:COVID-19 has presented every department an urgent challenge to deal with the mounting cataract HP cataract MESHD surgery waiting list. We present a pragmatic method of risk stratifying patients on waiting lists, blending an evidence-based objective assessment of risk and patient need combined with an element of shared decision-making. This has facilitated recommencement of our cataract HP cataract MESHD service taking into account biohazard measures of the COVID-19 era.

The ZB MED preprint Viewer preVIEW includes all COVID-19 related preprints from medRxiv and bioRxiv, from ChemRxiv, from ResearchSquare, from arXiv and from Preprints.org and is updated on a daily basis (7am CET/CEST).
The web page can also be accessed via API.

Sources


Annotations

All
None
MeSH Disease
Human Phenotype
Transmission
Seroprevalence


Export subcorpus as...

This service is developed in the project nfdi4health task force covid-19 which is a part of nfdi4health.

nfdi4health is one of the funded consortia of the National Research Data Infrastructure programme of the DFG.